HCAT Health Catalyst, Inc | US42225T1079
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 250.265.030 | 266.933.650 | 6.24% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 0,09 | 0,04 | 119.61% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 6 | 6 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |